PR Newswire Europe - First Study to Show Seroquel May be Effective in Rapid-Cycling Bipolar Disorder.
ALDERLEY PARK, Cheshire, UK, September 24 /PRNewswire/ —
- New data shows Seroquel works quickly and is well-tolerated in a difficult to treat patient population -
For Health Professional Press
Related Results
New SeroquelSeroquel indicationSeroquel Backgrounder.Seroquel approvedAZ’s Seroquel faces competition
AstraZeneca announced important new data presented today at the 4th European Stanley Foundation Conference on Bipolar Disorder, which show SEROQUEL is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder and is also well-tolerated in this difficult to treat patient population(1). The results are from the first large-scale, …
Read the rest of this article with a Free Trial at HighBeam Research.
